Date
The issue: Odan has issued a voluntary, type 3 recall for one lot of lidocaine 12 mg/dose endotracheal spray. This recall is due to a potential for the dispenser to leak. Type 3 recalls are defined by Health Canada as unlikely to cause adverse health effects. This recall has now contributed to a national shortage of the product, which is on backorder until at least July 2025. NH supply is low and conservation measures are needed to prevent a stock out.
Potential alternatives:
- Lidocaine solution can be administered via atomization device as needed:
- MADgic™ Laryngo-Tracheal Mucosal Atomization Device (item number: 5005140). Contact your local Respiratory Therapist or Dana Thomas (Regional Respiratory Practice Lead) for assistance as needed.
- Lidocaine solutions are available in 1% (10 mg/mL), 2% (20 mg/mL), and 4% (40 mg/mL) concentrations.